Levels of pyrimethamine in sera and cerebrospinal and ventricular fluids from infants treated for congenital toxoplasmosis. Toxoplasmosis Study Group

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  1992-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1128/AAC.36.5.1040PMID 1510391PMCID PMC188832
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Absence of Sensorineural Hearing Loss in Treated Infants and Children with Congenital Toxoplasmosis

  1992cited by this paper
• Isocratic reversed-phase HPLC method to measure pyrimethamine extracted from plasma of infants treated for toxoplasmosis.

  1991cited by this paper
• Phenotypes and functions of lymphocytes in congenital toxoplasmosis.

  1990cited by this paper
• Plasma concentrations of sulfadoxine-pyrimethamine and of mefloquine during regular long term malaria prophylaxis.

  1990cited by this paper
• Treatment of congenital toxoplasmosis.

  1990cited by this paper
• Pharmacokinetics of the combination pyrimethamine with sulfadoxine and mefloquine (FANSIMEF) in Chinese volunteers and the relative bioavailability of a lacquered tablet.

  1990cited by this paper
• Studies on the determination and degradation of pyrimethamine in mammals.

  1990cited by this paper
• Class I MHC genes and CD8+ T cells determine cyst number in Toxoplasma gondii infection.

  1990cited by this paper
• Zidovudine antagonizes the action of pyrimethamine in experimental infection with Toxoplasma gondii

  1989cited by this paper
• Single dose kinetic study of the triple combination mefloquine/sulphadoxine/pyrimethamine (Fansimef) in healthy male volunteers.

  1989cited by this paper
• Harrison's Principles of Internal Medicine

  1988cited by this paper
• Enzyme immunoassay to assess effect of antimicrobial agents on Toxoplasma gondii in tissue culture

  1988cited by this paper
• In vitro assessment of antimicrobial agents against Toxoplasma gondii.

  1988cited by this paper
• Pyrimethamine concentrations in serum and cerebrospinal fluid during treatment of acute Toxoplasma encephalitis in patients with AIDS.

  1988influential reference
• Pharmacokinetics of sulfadoxine and pyrimethamine after Fansidar administration in man.

  1987cited by this paper
• Decreased hepatic elimination of pyrimethamine during malaria infection. Studies in the isolated perfused rat liver.

  1987cited by this paper
• New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A

  1984cited by this paper
• Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection.

  1980cited by this paper
• Lipid-soluble inhibitors of dihydrofolate reductase. I. Kinetics, tissue distribution, and extent of metabolism of pyrimethamine, metoprine, and etoprine in the rat, dog, and man.

  1978cited by this paper
• The pharmacological properties of 2, 4-diamino-5-p-chlorophenyl-6-ethylpyrimidine, daraprim.

  1953cited by this paper

• The BAF complex inhibitor pyrimethamine reverses HIV-1 latency in people with HIV-1 on antiretroviral therapy

  2023cites this paper
• Building Programs to Eradicate Toxoplasmosis Part I: Introduction and Overview

  2022cites this paper
• Building Programs to Eradicate Toxoplasmosis Part IV: Understanding and Development of Public Health Strategies and Advances “Take a Village”

  2022cites this paper
• Development of a Method for Identification and Quantification of Sulfadiazine and Pyrimethamine in Serum of Congenital Toxoplasmosis Pediatric Patients

  2021cites this paper
• Development of a Method for Identification and Quantification of Sulfadiazine and Pyrimethamine in Serum of Congenital Toxoplasmosis Patients

  2021cites this paper
• Case Report: Immune Dysregulation Due to Toxoplasma gondii Reactivation After Allogeneic Hematopoietic Cell Transplant

  2021cites this paper
• The Surgical Management of Parasitic Diseases

  2020cites this paper
• Sulfadiazine plasma concentrations in women with pregnancy-acquired compared to ocular toxoplasmosis under pyrimethamine and sulfadiazine therapy: a case–control study

  2020cites this paper
• Human Toxoplasma infection

  2020cites this paper
• Antiparasitic treatments in pregnant women: Update and recommendations.

  2020cites this paper
• Ocular disease due to Toxoplasma gondii

  2020cites this paper
• Parasitic Infestations in Pregnancy: Surgical Challenges and Dilemmas

  2020cites this paper
• Outcomes of hydrocephalus secondary to congenital toxoplasmosis.

  2019cites this paper
• Targeting the Blood-Brain Barrier to Prevent Sepsis-Associated Cognitive Impairment

  2019cites this paper
• Seroprevalence of Toxoplasma Gondii Antibodies in Pregnant Women in Thrace Region of Turkey-A Tertiary Center Experience

  2019cites this paper
• Pyrimethamine inhibits rabies virus replication in vitro

  2019cites this paper
• Congenital Toxoplasmosis, Syphilis, Malaria, and Tuberculosis

  2018cites this paper
• Congenital Toxoplasmosis presenting as multiple ring enhancing lesions in brain on neuroimaging

  2018cites this paper
• Toxoplasma infection among pregnant women in Norway; susceptibility, diagnosis and follow-up

  2017cites this paper
• Newborn screening for congenital toxoplasmosis in Ireland

  2016cites this paper
• New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections

  2016cites this paper
• Treatment of Congenital Toxoplasmosis: Safety of the Sulfadoxine–Pyrimethamine Combination in Children Based on a Method of Causality Assessment

  2016cites this paper
• Reply to Wallon and Peyron.

  2016cites this paper
• Investigation of antimalarial drug pyrimethamine and its interaction with dsDNA by electrochemical and spectroscopic techniques

  2015cites this paper
• Management of Congenital Toxoplasmosis

  2014cites this paper
• Chapter 5 – Ocular Disease due to Toxoplasma gondii

  2014cites this paper
• Modification of Triclosan Scaffold in Search of Improved Inhibitors for Enoyl‐Acyl Carrier Protein (ACP) Reductase in Toxoplasma gondii

  2013cites this paper
• Pyrimethamine decreases levels of SOD1 in leukocytes and cerebrospinal fluid of ALS patients: A phase I pilot study

  2013cites this paper
• Postnatale Therapie der konnatalen Toxoplasmose: Ein Vergleich zweier unterschiedlicher Vorgehensweisen

  2012cites this paper
• Prematurity and severity are associated with Toxoplasma gondii alleles (NCCCTS, 1981-2009).

  2012cites this paper
• Impaired Innate Immunity in Mice Deficient in Interleukin-1 Receptor-Associated Kinase 4 Leads to Defective Type 1 T Cell Responses, B Cell Expansion, and Enhanced Susceptibility to Infection with Toxoplasma gondii

  2012cites this paper
• Análise genética e funcional da resposta imune na toxoplasmose ocular humana

  2012cites this paper
• Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America.

  2011cites this paper
• Monitoring of plasma concentration of pyrimethamine (PYR) in infants with congenital Toxoplasma gondii infection--own observations.

  2011cites this paper
• [Congenital toxoplasmosis treatment]

  2011cites this paper
• Clinical Manifestations of Ocular Toxoplasmosis

  2011cites this paper
• Pharmacokinetic Properties of Conventional and Double-Dose Sulfadoxine-Pyrimethamine Given as Intermittent Preventive Treatment in Infancy

  2011cites this paper
• Maternal Serologic Screening to Prevent Congenital Toxoplasmosis: A Decision-Analytic Economic Model

  2011cites this paper
• CHAPTER 31 – Toxoplasmosis

  2011cites this paper
• Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections

  2010cites this paper
• Chorioretinal lesions in mothers of children with congenital toxoplasmosis in the National Collaborative Chicago-based, Congenital Toxoplasmosis Study.

  2010cites this paper
• Evaluation of the effect of pyrimethamine, an anti-malarial drug, on HIV-1 replication.

  2010cites this paper
• Agents Active against Parasites and Pneumocystis

  2010cites this paper
• Why prevent, diagnose and treat congenital toxoplasmosis?

  2009influential citation
• In Vitro Susceptibility of Various Genotypic Strains of Toxoplasma gondii to Pyrimethamine, Sulfadiazine, and Atovaquone

  2008cites this paper
• Adaptive Immunity and Genetics of the Host Immune Response

  2007cites this paper
• Safety and Toxicity of Sulfadoxine/Pyrimethamine

  2007cites this paper
• Ocular Disease due to Toxoplasma gondii

  2007cites this paper
• Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study.

  2006cites this paper
• Chapter 31 – Toxoplasmosis

  2006cites this paper
• Impact of Visual Impairment on Measures of Cognitive Function for Children With Congenital Toxoplasmosis: Implications for Compensatory Intervention Strategies

  2006cites this paper
• Treatment of infants with congenital toxoplasmosis: tolerability and plasma concentrations of sulfadiazine and pyrimethamine

  2005cites this paper
• Toxoplasmosis, Syphilis, Malaria, and Tuberculosis

  2005cites this paper
• Simultaneous determination of pyrimethamine, sulfadiazine and N-acetyl-sulfadiazine in plasma for monitoring infants in treatment of congenital toxoplasmosis.

  2005cites this paper
• Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosis.

  2004cites this paper
• Population Pharmacokinetics of Pyrimethamine and Sulfadoxine in Children Treated for Congenital Toxoplasmosis

  2004cites this paper
• Perinatal infections and brain injury: current treatment options.

  2002cites this paper
• Prise en charge diagnostique et thérapeutique de la toxoplasmose congénitale

  2001cites this paper
• Options for the pharmacotherapy of toxoplasmosis during pregnancy

  2001cites this paper
• La prévention de la toxoplasmose congénitale en France. Évaluation des risques. Résultats et perspectives du dépistage anténatal et du suivi du nouveau-né

  2001cites this paper
• [Prevention of congenital toxoplasmosis in France. Risk assessment. Results and perspectives of prenatal screening and newborn follow up].

  2001cites this paper
• Intravitreal clindamycin and dexamethasone for toxoplasmic retinochoroiditis.

  2001cites this paper
• Congenital toxoplasmosis: Current status of diagnosis, treatment, and prevention

  2000cites this paper
• Management of and outcome for the newborn infant with congenital toxoplasmosis

  2000cites this paper
• Drugs effective against Toxoplasma gondii . Present status and future perspective

  2000cites this paper
• Azithromycin for ocular toxoplasmosis

  1998cites this paper
• Human maternofoetal distribution of pyrimethamine-sulphadoxine.

  1998cites this paper
• Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group.

  1998cites this paper
• Folic acid

  1998cites this paper
• Convulsion liée à un surdosage en pyriméthamine

  1996cites this paper
• Plasma pyrimethamine concentrations during long-term treatment for cerebral toxoplasmosis in patients with AIDS

  1996cites this paper
• Eye manifestations of congenital toxoplasmosis.

  1996cites this paper
• Eye manifestations of congenital toxoplasmosis.

  1996cites this paper
• [Convulsions associated with pyrimethamine overdose].

  1996cites this paper
• Resolution of intracranial calcifications in infants with treated congenital toxoplasmosis.

  1996cites this paper
• Study of treatment of congenital Toxoplasma gondii infection in rhesus monkeys with pyrimethamine and sulfadiazine

  1995cites this paper
• Relapse of Toxoplasma encephalitis and susceptibility to pyrimethamine: lack of evidence of treatment-induced resistance

  1995cites this paper
• Pyrimethamine analysis by enzyme inhibition and HPLC assays.

  1995cites this paper
• Congenital infection with Toxoplasma gondii.

  1994cites this paper
• Management strategies for congenital infections.

  1994cites this paper
• Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial.

  1994cites this paper
• Management strategies for infectious diseases in pregnancy.

  1994cites this paper